Class Action

Advil, Tylenol, DayQuil, NyQuil, TheraFlu, Sudafed, and Other Cold and Flu Medicines

Class Action

Advil, Tylenol, DayQuil, NyQuil, TheraFlu, Sudafed, and Other Cold and Flu Medicines


Case Name (Date)

Chamberlain et al. v. Johnson & Johnson Consumer Inc., RB Health LLC, GlaxoSmithKline Consumer Healthcare Holdings (US), LLC
23-cv-4435, E.D. Penn.
(Nov. 2023)

Travis et al. v. Procter & Gamble Co., Kenvue, Inc., McNeil Consumer Healthcare, Reckitt & Benckiser LLC and GlaxoSmithKline, LLC
23-cv-607, S.D. Ohio
(Sept. 2023)


Product/Service

Advil, Tylenol, DayQuil, NyQuil, TheraFlu, Sudafed, and other cold and flu medicines


Allegations

Falsely marketing that medicines are decongestants when the active ingredient (phenylephrine) is not an effective decongestant


Status

Pending



Class-Action Tracker


The Latest

Filters

Microban 24

Ad Alert

Microban 24

Sanitizing spray does not provide 24-hour protection against viruses, despite what its TV commercial may make you think.

Benefiber

Ad Alert

Benefiber

If you see a supplement marketed as “clinically proven,” pump your brakes.

Tide Purclean

Ad Alert

Tide Purclean

Laundry detergent’s “plant-based” claims come under scrutiny.

Cascade Platinum

Ad Alert

Cascade Platinum

Detergent brand uses greenwashing in effort to convince consumers that running a less than full dishwasher is actually good for the environment.


Show More